Observations by Wright and collaborators suggest that higher Fibroblast Growth Factor 23 (FGF-23)—a bone-derived hormone that regulates phosphorus homeostasis and that is often elevated in patients with CKD—is associated with increased risk of stroke even in patients with normal kidney function [10]. The gene discussed is FGF23; the disease is Stroke.